NC BioNetwork - Novartis

The threat of the next flu pandemic brought Novartis and the United States government together to draft a comprehensive plan for outbreak preparedness. The ability of North Carolina to train the work force needed to implement that plan brought Novartis to the Tar Heel State. The result of this multi-faceted partnership is an innovative $1-billion flu vaccine facility in Holly Springs, N.C., covering 430,000 sq. ft. (39,947 sq. m.) and employing 400 workers. Expected to be fully operational in 2013, the plant will be equipped to produce 150 million doses of pandemic influenza vaccine within six months. READ MORE.